These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19542539)

  • 1. Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals.
    Scott PA; Turner NG; Chungh A; Morgan JM; Roberts PR
    Europace; 2009 Aug; 11(8):1048-51. PubMed ID: 19542539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do some implant too many defibrillators or others too few?
    Israel CW
    Europace; 2009 Aug; 11(8):982-4. PubMed ID: 19635816
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
    Haugaa KH; Tilz R; Boveda S; Dobreanu D; Sciaraffia E; Mansourati J; Papiashvili G; Dagres N
    Europace; 2017 Apr; 19(4):660-664. PubMed ID: 28431077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.
    Sadarmin PP; Wong KC; Rajappan K; Bashir Y; Betts TR
    Europace; 2014 Nov; 16(11):1575-9. PubMed ID: 24668515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.
    Lampert R; Wang Y; Curtis JP
    Am Heart J; 2013 Jun; 165(6):1015-1023.e2. PubMed ID: 23708175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
    Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Variation in Implantable Cardioverter Defibrillator Therapy Guideline Adherence With Physician and Hospital Patient-sharing Networks.
    Moen EL; Bynum JP; Austin AM; Skinner JS; Chakraborti G; O'Malley AJ
    Med Care; 2018 Apr; 56(4):350-357. PubMed ID: 29419707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
    Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questionnaire survey of cardiologists' knowledge, attitudes, and guideline application of implantable cardioverter defibrillator therapy.
    Sadarmin PP; Wong KC; Rajappan K; Bashir Y; Betts TR
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):672-80. PubMed ID: 22452348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of predictive modeling in implementing optimal heart failure therapy.
    Prasad H; Sra J; Levy WC; Stapleton DD
    Am J Med Sci; 2011 Mar; 341(3):185-90. PubMed ID: 21233695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of indications for device therapy among a broad range of physicians: a survey study.
    Hübinette C; Lund LH; Gadler F; Ståhlberg M
    Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system.
    Gillis AM
    Can J Cardiol; 2005 May; 21 Suppl A():25A-30A. PubMed ID: 15953941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience.
    Schuler PK; Herrey A; Wade A; Brooks R; Peebles D; Lambiase P; Walker F
    Europace; 2012 Dec; 14(12):1740-5. PubMed ID: 22744770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low referral pattern for implantable defibrillator therapy in a tertiary hospital: referral physician survey and Monte Carlo simulation.
    Mohamad T; Jacob S; Kommuri NV; Modi S; Aravindhakshan R; Lieberman R
    Am J Ther; 2011 Sep; 18(5):350-4. PubMed ID: 20335787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current implantable cardioverter-defibrillator programming in Europe: the results of the European Heart Rhythm Association survey.
    Proclemer A; Grazia Bongiorni M; Etsner H; Todd D; Sciaraffia E; Blomström-Lundqvist C;
    Europace; 2014 Jun; 16(6):935-8. PubMed ID: 24864305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of implantable cardioverter defibrillators in the New Zealand context from 2000 to 2007.
    Larsen PD; De Silva P; Harding SA; Woodcock E; Lever NA
    N Z Med J; 2010 Feb; 123(1309):76-85. PubMed ID: 20186244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators.
    McHale B; Harding SA; Lever NA; Larsen PD
    Europace; 2009 Oct; 11(10):1313-6. PubMed ID: 19734156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.